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The Ly49E receptor is preferentially expressed on
murine innate-like lymphocytes, such as epidermal
Vg3 T cells, intestinal intraepithelial CD8aa+ T lym-
phocytes, and CD49a+ liver natural killer (NK) cells.
As the latter have recently been shown to be distinct
from conventional NK cells and have innate lymphoid
cell type 1 (ILC1) properties, we investigated Ly49E
expression on intestinal ILC populations. Here, we
show that Ly49E expression is very low on known
ILC populations, but it can be used to define a previ-
ously unrecognized intraepithelial innate lymphoid
population. This Ly49E-positive population is nega-
tive for NKp46 and CD8aa, expresses CD49a and
CD103, and requires T-bet expression and IL-15
signaling for differentiation and/or survival. Tran-
scriptome analysis reveals a group 1 ILC gene profile,
different from NK cells, iCD8a cells, and intraepithe-
lial ILC1. Importantly, NKp46CD8aaLy49E+ cells
produce interferon (IFN)-g, suggesting that this pre-
viously unrecognized population may contribute to
Th1-mediated immunity.
INTRODUCTION
In recent years, several innate lymphoid cell (ILC) populations
have been described. Characterized by the absence of rear-
ranged antigen-specific receptors, these cells have been classi-
fied into group 1, 2, and 3 ILCs, with each group mirroring a
respective T helper cell population (Fuchs et al., 2013; KloseCell
This is an open access article under the CC BY-Net al., 2014; Robinette et al., 2015). Group 1 ILCs comprise nat-
ural killer (NK) cells and ILC1 that are defined by a dependence
on the Eomes or T-bet transcription factors, respectively. These
cells have the capacity to respond to interleukin (IL)-12, IL-15,
and IL-18 to produce interferon (IFN)-g (Fuchs et al., 2013; Klose
et al., 2014). Group 2 ILCs are defined by a dependence on the
transcription factors RORa and GATA-3 and the capacity to
respond to IL-33, IL-25, and thymic stromal lymphopoietin to
produce type 2 cytokines, such as IL-5 and IL-13. Lastly, group 3
ILCs are defined by a dependence on RORgt and the capacity to
respond to IL-1b and IL-23 by the production of IL-22, IL-17A,
and/or IL-17F (Fuchs et al., 2013; Klose et al., 2014; Robinette
et al., 2015; Tait Wojno and Artis, 2012).
Abundant at mucosal barrier surfaces (Klose et al., 2014; Rob-
inette et al., 2015), ILCs have been assigned important roles in a
number of immunological processes. Whereas ILC1s have been
implicated in the control of intracellular parasite infections (Klose
et al., 2014; Schulthess et al., 2012) and gut inflammation (Ber-
nink et al., 2013b; Fuchs et al., 2013), ILC2s are important in
the clearance of helminth (Neill et al., 2010) and viral infections
(Monticelli et al., 2011) and in the progression of asthma and
lung allergies (Chang et al., 2011; Mjo¨sberg et al., 2011; Nuss-
baum et al., 2013; Spits and Cupedo, 2012; Klein Wolterink
et al., 2012). ILC3s, in turn, contribute to tertiary lymphoid organ-
ogenesis (van de Pavert and Mebius, 2010), the containment of
commensal bacteria (Sonnenberg and Artis, 2012), and clear-
ance of bacterial infections in the gut (Cella et al., 2009; Diefen-
bach, 2013; Klose et al., 2013; Satoh-Takayama et al., 2008;
Sonnenberg et al., 2011), and they have been implicated in the
pathology of inflammatory bowel disease (Bernink et al.,
2013b; Buonocore et al., 2010; Geremia et al., 2011). It should
be noted that some of the described functions are attributable
to ex-RORgt+ ILC3s (Bernink et al., 2013b; Vonarbourg et al.,Reports 19, 1431–1443, May 16, 2017 ª 2017 The Author(s). 1431
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2010), where bidirectional functional plasticity between ILC1 and
ILC3 classes in response to distinct environmental stimuli was
recently demonstrated (Bernink et al., 2015).
Whereas group 2 ILCs appear to be the most homogeneous
cells, considerable heterogeneity exists within group 1 and 3
ILCs. In the gut, a distinction can be made within group 1 ILCs
among conventional natural killer (cNK) cells, lamina propria
(Klose et al., 2014) and intraepithelial ILC1s (Fuchs et al.,
2013), and ex-RORgt+ ILC3s (Bernink et al., 2013b; Vonarbourg
et al., 2010). The cNK cells are considered to be
CD27+CD127(IL-7Ra)NKp46+NK1.1+ cells that express both
Eomes and T-bet. Whereas cNK cells are dramatically reduced
in EomesF/F 3 Vav-Cre mice (Gordon et al., 2012), they are
only slightly reduced in Tbx21/mice (Klose et al., 2014; Town-
send et al., 2004). NK cells are cytotoxic in nature, and they may
also be stimulated to produce the signature cytokine IFN-g.
Intraepithelial ILC1 (Fuchs et al., 2013) and lamina propria ILC1
(Klose et al., 2014) have a CD27+CD127+NKp46+NK1.1+ pheno-
type. Intraepithelial ILC1s, similar to NK cells, express both
Eomes and T-bet. However, in contrast to cNK cells, intraepithe-
lial ILC1s are largely independent of IL-15Ra (Fuchs et al., 2013).
Lamina propria ILC1s express T-bet, but not Eomes, rely on IL-
15 for their maintenance/survival, and express IFN-g upon stim-
ulation (Klose et al., 2014). Lastly, ex-RORgt ILC3s originate from
RORgt+ ILC3s that have downregulated RORgt and have upre-
gulated T-bet and NKp46 expression. These ex-RORgt ILC3s
are considered to be ILC1-like cells. Upon stimulation, these
cells may also produce IFN-g. At present, ex-RORgt ILC3s can
only be distinguished from bona fide lamina propria ILC1 with
the aid of RORgt-fate map mice. Within group 3 ILCs, four sub-
sets can be distinguished as follows: CD4NKp46CCR6+
RORgt+ and CD4+CCR6+NKp46RORgt+ lymphoid tissue
inducer (LTi)-like ILC3s and NKp46RORgt+ and NKp46+
RORgt+ ILC3s (Robinette et al., 2015). Recently, CD8aa+
innate-type lymphocyte (iCD8a) cells, an innate lymphoid popu-
lation resident to the intestinal epithelium, were also described
(Van Kaer et al., 2014).
Ly49E, a member of the Ly49 NK receptor family, is preferen-
tially expressed on innate lymphocytes. In this respect, the
Ly49E receptor is expressed on innate-like epidermal Vg3
T cells as well as intestinal CD8aa+ intraepithelial T lymphocytes
(Taveirne et al., 2011; Van Acker et al., 2014; Van Beneden et al.,
2002). Alongside, Ly49E expression is low on cNK cells from
adult mice (Van Beneden et al., 2001), but it is highly expressed
on CD49a+ liver NK cells (Filtjens et al., 2013). Interestingly, the
latter have recently been shown to have ILC1-like properties
(Robinette et al., 2015; Tang et al., 2016). As such, we investi-
gated whether Ly49E is expressed on intestinal ILC populations.
In this paper we show that, whereas Ly49E expression is low on
conventional ILC1 and ILC3 populations, Ly49E defines a previ-
ously unrecognized NKp46-negative intraepithelial lymphocyte
(IEL) population that can be minimally characterized as
NKp46 CD8aa Ly49E+. This intestinal IEL population requires
IL-15-mediated, but not IL-7-mediated, signaling for mainte-
nance; is dependent on T-bet, but not on Eomes or RORgt;
and has a gene expression profile that is closely related to
both lamina propria ILC1 and NK cells. Importantly, in vitro stim-
ulation with IL-12, IL-15, and IL-18, or in vivo Toxoplasma gondii1432 Cell Reports 19, 1431–1443, May 16, 2017infection, induces IFN-g expression by these cells, confirming
the ILC1-like nature and the capacity to contribute to Th1-medi-
ated immune responses.
RESULTS
Ly49E Is Primarily Expressed on NKp46-Negative
Intestinal IEL
We have previously shown that the Ly49E receptor is expressed
on several innate-like cell populations in adult C57BL/6 mice
(Filtjens et al., 2013; Taveirne et al., 2011; Van Acker et al.,
2014; Van Beneden et al., 2002). Recent years have seen the dis-
covery of a number of innate lymphoid populations, i.e., the ILCs,
with particular diversity of these cells in the small intestine (Rob-
inette et al., 2015). Klose et al. (2014) demonstrated that intesti-
nal ILC populationsmay be successfully segregated on the basis
of CD27 and CD127 expression. As such, we set out to investi-
gate whether Ly49E is expressed on small intestinal ILC subsets.
Our results showed that Ly49E was expressed only by a small
subpopulation of intraepithelial NKp46+NK1.1+ ILCs: 2%–5%
of CD27+CD127 cNKs expressed Ly49E, Ly49E expression
was even lower on CD27+CD127+ ILC1s, and it was almost ab-
sent on CD27CD127+ ILC3s. A small number of CD27CD127
cells could also be detected within the NK1.1+NKp46+-gated
lymphocytes. We hypothesized that these cells represent termi-
nally differentiated NK cells, as loss of CD27 expression on such
cells in the periphery has previously been reported (Hayakawa
and Smyth, 2006). Comparable to CD27+ NK cells, a mean of
2.5% of CD27CD127 NK cells expressed Ly49E (data not
shown). Similarly, Ly49E expression was low/absent on lamina
propria NKp46+NK1.1+ ILC populations (Figure 1A). Importantly,
Ly49E expression was most abundant on the NKp46 subpopu-
lation of intraepithelial CD3CD45+ cells. Whereas the percent-
age of Ly49E-expressing cells in the total CD3CD45+ NKp46
population was relatively low (Figure 1A), the absolute number
of these cells was 7-fold higher as compared to the Ly49E-ex-
pressing CD3CD45+NKp46+ intestinal IEL fraction (Figure 1B).
Even higher absolute numbers of CD3CD45+NKp46Ly49E+
IELs were present in the small intestine of Rag/ and NOD-
SCID mice (Figures 1C and 1D), confirming their innate nature.
Therefore, for practical purposes, all future experiments were
performed with small intestinal IELs of Rag/ or NOD-SCID
mice.
NKp46-Negative Ly49E+ IELs Have an ILC-like/Non-NK
Surface Phenotype and a Granular Lymphoid
Morphology
Based on CD4, CD8b, and CD8a expression, two main sub-
populations of CD3CD45+NKp46Ly49E+ cells could be distin-
guished that wereCD8aa+ andCD8aa, respectively (Figure 2A).
We further performed a detailed phenotypic characterization of
these two populations and of spleen NK cells for comparison.
Both CD8aa and CD8aa+ Ly49E-expressing populations were
CD49a+CD103+ (Figure 2B), suggestive of a tissue-resident
intraepithelial ILC phenotype (Fuchs et al., 2013; Robinette
et al., 2015). A fraction of cells from both populations expressed
CD49b but at lower levels compared to NK cells. Further-
more, both populations were CD127CD27CD11bintCD11cint
Figure 1. Ly49E Expression in NKp46+ and NKp46 Innate Lymphocytes in the Intestinal Epithelium and Lamina Propria
(A) Flow cytometric analysis of small intestinal innate IELs and LPLs from WT mice. cNK-, ILC1-, ILC3-, and NKp46-negative cells were gated as indicated and
analyzed for Ly49E expression.
(B) Absolute numbers (mean ± SEM; n = 5) of small intestinal intraepithelial NKp46+ cNK cells, ILC1s, and ILC3s and NKp46 cells in WT mice and the absolute
numbers of Ly49E-expressing cells therein.
(C) Flow cytometric analysis of small intestinal IEL from WT, Rag/, and NOD-SCID mice. NKp46 cells were first gated for Ly49E expression and analyzed for
CD3 and CD45 expression.
(D) Absolute numbers (mean ± SEM; n = 5) of CD3CD45+NKp46Ly49E+ cells in the small intestinal epithelium of C57BL/6, Rag/, and NOD-SCID mice.
Statistical analysis was performed using the two-tailedMann-Whitney U test (***p < 0.001). (A and C) Numbers in the dot plots represent the percentage of cells in
the indicated gate or quadrant. Data are representative of five independent experiments.
Cell Reports 19, 1431–1443, May 16, 2017 1433
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Figure 2. Surface Marker Expression of Intestinal NKp46-Negative CD8aaLy49E+ and CD8aa+Ly49E+ IELs
(A) CD8aa and CD8aa+ subpopulations were identified in intestinal CD45+NKp46Ly49E+ IELs from Rag/ mice, as indicated.
(B) Surface expression profile of CD8aaLy49E+ (red line) and CD8aa+Ly49E+ (blue line) cells, gated as in (A) and stained with the indicated antibodies. The black
line represents spleen NK cell staining. Gray-shaded histograms represent Fluorescence Minus One controls. Data are representative of three independent
experiments.
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Figure 3. Intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs Have a
Lymphoid Morphology
CD8aa+Ly49E+ and CD8aaLy49E+ cells, additionally gated as CD3CD45+
NKp46, were sorted to high purity (>98%) from small intestinal IELs of NOD-
SCID mice. Intestinal intraepithelial CD3+CD45+Ly49E+ T lymphocytes were
sorted from WT mice. Cells were fixed and stained with Giemsa.CD117/intCD90Sca-1CD122intNK1.1int.While CD8aa+Ly49E+
cells were negative for NKG2A/C/E, the CD8aaLy49E+ popula-
tion showed intermediate expression for thisNK cell receptor.We
did not detect expression of NKG2D or other (non-Ly49E) Ly49
receptors on either of these populations (Figure 2B). In this,
CD8aa+Ly49E+ cells strongly resembled CD8aa+ innate-type
lymphocytes (iCD8a) cells (Van Kaer et al., 2014), whereas
CD8aaLy49E+ cells defined a previously undescribed IEL pop-
ulation with innate-type surface marker expression. Cytospins
of sorted CD8aaLy49E+ and CD8aa+Ly49E+ IELs, and of
CD3+Ly49E+ intraepithelial T cells for comparison, showed that
both Ly49E-expressing cell populations had a lymphoid
morphology and were highly granular (Figure 3).
Intestinal NKp46-Negative CD8aaLy49E+ and
CD8aa+Ly49E+ IELsHave aDistinct Transcription Factor
Expression Profile and Dependency
ILCs may be classified into group 1, 2, or 3 ILCs on the basis of
transcription factor expression and dependency. Intracellular
staining of intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs
revealed that both populations lacked Eomes expression, in
contrast to NK cells, but expressed T-bet. Whereas a very small
proportion of CD8aaLy49E+ cells was RORgt positive, CD8aa+
Ly49E+ cells did not express RORgt (Figure 4A). When
CD8aaLy49E+ and CD8aa+Ly49E+ cells were isolated from
RORgt-fate map (fm) mice, a minor fraction of cells from each
subpopulation was RORgt-fm positive (Figure 4B), suggesting
that only a few cells are ex-RORgt+ ILC3s that have lost
RORgt expression (Bernink et al., 2013b, 2015). Alternatively,
the minor fraction of RORgt- or RORgt-fm-positive cells in the
CD8aaLy49E+ IELs could be contaminating LTi cells from the
lamina propria. Complete separation of epithelium and laminapropria gut fractions is technically challenging with the currently
available methods, and as such a small number of LTi RORgt+
cells may account for the RORgt signal in a minor fraction of
CD8aaLy49E+ IELs.
To analyze the transcriptional programs required for differ-
entiation or maintenance of Ly49E+ ILCs, the cell numbers
of intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs, and
as controls the cNK, ILC1, and NKp46+ ILC3 populations,
were determined in Eomes/, Tbx21/, and Rorc(gt)/. As
compared to wild-type (WT) mice, even greater numbers
of CD8aaLy49E+ and CD8aa+Ly49E+ IELs were present in
Eomes/ mice. It has previously been observed that in mice
genetically lacking one ILC population, other ILC populations
are increased (Sanos et al., 2009). At current, the mechanistic
basis for this finding is unknown. We hypothesize that this may
be due to competition of ILC subsets for space or higher avail-
ability of ILC-sustaining cytokines, such as IL-15. Additionally,
the lack of competition with NK cells for IL-15 in Eomes/
mice could support not only expansion but also survival
of these IELs. Tbx21/ mice had strongly reduced numbers
of CD8aa+Ly49E+ and CD8aaLy49E+ IELs. Numbers of
CD8aaLy49E+ and CD8aa+Ly49E+ cells were unaffected in
Rorc(gt)/ mice. Control populations showed the expected
transcription factor dependency, as NK cells were virtually ab-
sent in Eomes/ mice, whereas ILC1s and NKp46+ ILC3s
were strongly reduced or absent, respectively, in Tbx21/
mice, and ILC3s were strongly reduced in Rorc(gt)/ mice
(Figure 4C).
NKp46-Negative CD8aaLy49E+ and CD8aa+Ly49E+
IELs Are Dependent on IL-15, but Not IL-7, Signaling
Previous studies have shown that ILCs require signaling through
the common gamma chain (gc) for their survival (Bernink et al.,
2013a, 2013b; Satoh-Takayama et al., 2010). To investigate
the cytokine dependency of intestinal CD8aaLy49E+ and
CD8aa+Ly49E+ IELs, we determined their cell numbers in Il2rg
(gc)/, Il7ra/, and Il15ra/ mice. As shown in Figure 5,
CD8aaLy49E+ IELs were increased in number in Il7ra/ mice
and absent in Il15ra/ and gc/ mice. This is in agreement
with the absence of CD127 on these cells but intermediate levels
of CD122 expression (Figure 2B). Increased ILC numbers have
previously been reported in the gut of Il7r/ mice (Klose et al.,
2014; Vonarbourg et al., 2010). CD8aa+Ly49E+ IELs were
similarly independent of IL-7 and dependent on IL-15 signaling
(Figure 5), as previously reported for iCD8a cells (Van Kaer
et al., 2014).
NKp46-Negative CD8aaLy49E+ IELs Have a Group 1
ILC-like Transcriptome
To gain a better understanding of the lineage relationship and
potential function of NKp46Ly49E+ cells, we carried out a
global transcriptome analysis of sorted CD8aaLy49E+,
CD8aa+Ly49E+, and CD8aa+Ly49E intestinal NKp46 IEL
populations, and we aligned our data with that of publicly
available gene expression data of intestinal iCD8a cells and
ILC subsets, including NK cells (Robinette et al., 2015; Van
Kaer et al., 2014). Non-supervised hierarchical clustering
revealed that CD8aaLy49E+ cells clustered closely withCell Reports 19, 1431–1443, May 16, 2017 1435
AB
C
Figure 4. Transcription Factor Expression and Dependency of Intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs
(A) Expression of Eomes, T-bet, and RORgt by intestinal CD8aaLy49E+ (red line) and CD8aa+Ly49E+ IELs (blue line) and spleen NK cells (black line) of NOD-
SCID mice. The light shaded histogram represents non-stained cells.
(B) Analysis of small intestinal CD8aaLy49E+ (red line) andCD8aa+Ly49E+ IELs (blue line) and spleenNK cells (black line) fromRORgt-fatemap (Rorc(gt)-CreTg3
Rosa26RGfp/+) reporter mice. The expression of RORgt-fatemap (fm) is shown in the indicated populations. (A andB) Data are representative of three independent
experiments.
(C) Absolute numbers (mean ± SEM; n = 2–3) of the indicated IEL populations in WT, EomesD/D, Tbx21/, and Rorc(gt)Gfp/Gfp mice. Statistical analysis was
performed using the two-tailed Mann-Whitney U test (**p < 0.01 and ***p < 0.001).lamina propria-localized ILC1s and NK cells and partially
separated from iCD8a and from IEL, liver, or spleen ILC1s.
CD8aaLy49E+ IELs did not cluster with ILC2 and ILC3
populations. CD8aa+Ly49E+ IELs clustered with iCD8a cells
(Figure 6A).
More detailed gene expression analysis showed that
CD8aaLy49E+ IELs, in contrast to CD8aa+Ly49E+ IELs,
showed increased transcript levels of Rorc, Rora, and Eomes.
In accordance with the flow cytometric data, Tbx21 (T-bet)
expression levels were high in CD8aaLy49E+ IELs, and they
were comparable to those of NK and intestinal intraepithelial
and lamina propria ILC1 populations. Both CD8aaLy49E+ and
CD8aa+Ly49E+ IEL subsets expressed high levels of Id2, which
is required for the development of all ILC subsets (Spits and
Cupedo, 2012) (Figure 6B). Cytokine and cytokine receptor
expression profiles indicated that CD8aaLy49E+ IELs showed1436 Cell Reports 19, 1431–1443, May 16, 2017increased expression of the chemokine receptor CCR9. Both
CD8aaLy49E+ and CD8aa+Ly49E+ IELs expressed high levels
of the chemokines CCL3 (MIP1a) and CCL5 (RANTES) (Fig-
ure 6C). CD8aaLy49E+ IELs showed increased expression of
Ifng and Tnf as compared to CD8aa+Ly49E IELs. Additionally,
CD8aaLy49E+ IELs differed significantly from CD8aa+Ly49E
IELs in the expression of cytokine receptors, where CD8aa
Ly49E+ IELs highly expressed Il2ra, Il7r, and Il18r1, while only
low expression of these genes could be detected in CD8aa+
Ly49E+ IELs. Il2rb and Il12rb were expressed at high and
intermediate levels, respectively, in both populations. CD8aa
Ly49E+ IELs expressed Prf1, Grzma, and Grzmb, but levels
were lower than in CD8aa+Ly49E+ IELs (Figure 6D). Finally,
comparative analysis of the expression levels of genes of
the recently described NK cell-distinct ILC core signature (Rob-
inette et al., 2015) showed that these genes were expressed
Figure 5. Intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs Are
Dependent on IL-15 Signaling
Absolute numbers (mean ± SEM; n = 3) of CD8aaLy49E+ and CD8aa+Ly49E+
IELs of WT, Il7ra/, Il15ra/, and yc/ mice. Statistical analysis was per-
formed using the two-tailed Mann-Whitney U test (***p < 0.001).to a greater extent by CD8aaLy49E+ IELs as compared to
CD8aa+Ly49E IELs (Figure 6E, upper panel), whereas the
majority of NK-specific signature genes were only expressed
at low levels (Figure 6E, lower panel).
Transcriptome analysis of CD8aa+Ly49E IELs showed that
the gene expression profile of these cells is indistinguishable
from that of CD8aa+Ly49E+ IELs and highly similar to that of
iCD8a cells (Figures 6A–6E).
The analysis of phenotype, transcription factor and cytokine
dependency, and transcriptome of CD8aaLy49E+ IELs strongly
suggests that these are not NK cells, ILC2s, or ILC3s. To addi-
tionally exclude the possibility that the CD8aaLy49E+ IELs
represent a developmental intermediate, sorted cells were adop-
tively transferred to immunodeficient recipients, and the pheno-
type of these cells in the recipient gut was analyzed 2 weeks
following transfer. Our results demonstrate that CD8aaLy49E+
IELs represented a stable population, with 80%–97% retention
of Ly49E expression (Figure S1). Intestinal NKp46+ IELs were
transferred as a control. As expected, these cells were stable
upon transfer, with a minor fraction of cells expressing Ly49E,
similar to the starting donor population (Figure S1).In summary, transcriptome analysis of CD8aaLy49E+ IELs re-
veals that they have a transcriptional profile that displays charac-
teristics of core ILC subsets and a close correlation with both
lamina propria ILC1 and NK cell expression profiles. In addition,
these cells have a stable phenotype, and, as such, they represent
a previously undescribed intraepithelial ILC population. In paral-
lel, CD8aa+Ly49E+ IELs have many similarities with iCD8a cells.
CD8aa Ly49E+ Cells Do Not Kill YAC-1 Cells but
Produce IFN-g
Both intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IEL popula-
tions contain cytoplasmic granules (Figure 3) and express Prf1,
Gzma, andGzmbmRNA (Figure 6D). Intracellular flow cytometric
analysis confirmedperforin,granzymeA,andgranzymeBexpres-
sion at the protein level (Figure 7A), indicating that these cell
populations may have cytotoxic potential. We therefore sorted
these cells to high purity and tested their capacity to kill NK-sen-
sitive YAC-1 cells. Neither CD8aaLy49E+ nor CD8aa+Ly49E+
IELs killed YAC-1 cells, whereas the tested control populations,
i.e., intestinal intraepithelial and splenic NK cells, displayed effi-
cient cytotoxicity (Figure 7B). Collectively, this indicates that the
CD8aaLy49E+ andCD8aa+Ly49E+ IELsare potentially cytotoxic
but that they do not have the capacity to kill YAC-1 cells.
As CD8aaLy49E+ IELs displayed intermediate expression
of Il12rb and strong expression of Il2rb and Il18ra, we stimulated
intestinal IELs in vitro with IL-12, IL-15, and/or IL-18 and
determined IFN-g expression. Whereas CD8aa+Ly49E+ IELs
expressed moderate levels of IFN-g following stimulation with
IL-12 + IL-15 + IL-18, CD8aaLy49E+ IELs were avid producers
of IFN-g (Figure 7C). With respect to the function of the Ly49E
receptor in the immune system, our group has conclusively
demonstrated that Ly49E is an inhibitory receptor in NK cells,
restricting NK cell cytotoxicity and cytokine production upon
interaction with its ligand uPA (Van Den Broeck et al., 2008).
We therefore also stimulated the cells with IL-12 + IL-15 + IL-
18 in the presence of uPA or BSA as a negative control. The
presence of uPA did not alter IFN-g production of cytokine-stim-
ulated CD8aaLy49E+ or CD8aa+Ly49E+ IELs (Figure 7D).
These results suggest that CD8aaLy49E+ IELs, similarly to
NK cells and ILC1s, may be involved in mediating Th1-type
immunity. To test this, we assessed a putative function for
these cells in mediating T. gondii immunity. Our results indicate
that CD8aaLy49E+, but not CD8aa+Ly49E+, IELs contribute in
immunity to T. gondii infection through production of IFN-g (Fig-
ure 7E). As a control, we confirmed that IFN-g was produced by
lamina propria ILC1s upon T. gondii infection (data not shown),
as previously described by Klose et al. (2014).
DISCUSSION
The intestinal epithelium harbors a number of lymphocyte pop-
ulations, including innate-like and adaptive T cells, NKp46-ex-
pressing NK cells and ILC1s, and the recently described iCD8a
cells (Fuchs et al., 2013; Van Kaer et al., 2014). In this paper,
we show that the intestinal epithelium is also home to a
previously unrecognized CD3 innate population that can be
minimally characterized as NKp46CD8aaLy49E+. Further
study of these cells revealed a lymphoid morphology and aCell Reports 19, 1431–1443, May 16, 2017 1437
Figure 6. The Transcriptome of Intestinal CD8aaLy49E+ IEL Clusters with that of Lamina Propria-Localized ILC1s and NK Cells
Intestinal CD8aaLy49E+, CD8aa+Ly49E+, and CD8aa+Ly49E IELs, additionally gated as CD3CD45+, were sorted to high purity (>98%) from NOD-SCID mice
in three different experiments. Transcriptome analysis was performed, and it was compared to publicly available gene expression data of intestinal IELs and/or
lamina propria NK, ILC1, ILC2, NKp46+ ILC3, and CD4 or CD4+ ILC3 lymphoid tissue inducer (LTi) cells (see the Experimental Procedures).
(A) Non-supervised hierarchical clustering of the indicated populations based on all expressed genes is shown.
(B–E) Comparative analysis of individual gene transcript expression between the indicated cell subpopulations for the indicated gene groups.
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Figure 7. CD8aaLy49E+ Innate Lymphocytes Do Not Kill YAC-1 Target Cells, but They Express IFN-g
(A) Intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs were gated as in Figure 2A, and intracellular expression of the indicated proteins is shown. Spleen NK cells
are shown for comparison. Shaded histograms represent Fluorescence Minus One controls. Data are representative of three independent experiments.
(B) Intestinal CD8aaLy49E+ and CD8aa+Ly49E+ IELs, as well as intestinal intraepithelial and splenic NK cells, were sorted and tested for their YAC-1 killing
capacity in a 51Cr-release assay. The specific killing as a function of the effector:target (E:T) ratio is shown. Data shown are representative of three independent
experiments.
(C) Intestinal IELs were isolated from NOD-SCIDmice and stimulated with the indicated cytokines, after which IFN-g expression was determined. Numbers in the
right quadrant represent the percentage of IFN-g-expressing cells in the indicated population. Results are representative of three independent experiments.
(D) Intestinal intraepithelial cells were stimulated with IL-12 + IL-15 + IL-18 in the presence of coated uPA or BSA, as indicated, after which IFN-g expression was
determined. The percentage of IFN-g+ cells in the CD8aaLy49E+ and CD8aa+Ly49E+ gates is shown for each condition (mean ± SEM; n = 3).
(E) Analysis of IFN-g expression by CD8aaLy49E+ and CD8aa+Ly49E+ cells in NOD-SCID mice 4 days following oral gavage of mice with T. gondii cysts
(infected; black line) or PBS (uninfected; shaded gray). The percentage of IFN-g-positive cells is indicated. Results are representative of n = 3 mice.CD103+CD127 surface phenotype. CD103 is expressed by
intestinal epithelium-homing leukocytes, including T cells and
iCD8a cells. As such, CD103 expression reflects the intraepithe-
lial localization of CD8aaLy49E+ IELs. CD127 surface expres-
sion may be used to identify ILCs, except NK cells, in many
mouse tissues (Robinette et al., 2015). CD8aaLy49E+ IELs did
not express cell surface CD127. However, microarray analysis
revealed large numbers of Il7r transcripts, suggesting that Il7r
expression may not, or not sufficiently, be translated onto the
protein level in these cells to allow flow cytometric detection.Alternatively, CD8aaLy49E+ IELs may reside in an IL-7hi envi-
ronment and downregulate CD127. As intraepithelial ILC1 and
iCD8a cells have also been shown to lack detectable surface
expression of CD127 (Fuchs et al., 2013; Van Kaer et al.,
2014), it is worthwhile to consider that absence of CD127 on
the surface membrane of these three cell populations may
be a feature of their intraepithelial localization, whereas ILCs
located in the lamina propria are CD127+ (Klose et al., 2014).
This notion is further corroborated by data from human studies,
which have also described the existence of intraepithelialCell Reports 19, 1431–1443, May 16, 2017 1439
CD103+ ILC1 cells that are CD127lo/ (Hazenberg and Spits,
2014).
Specification of intestinal CD8aaLy49E+ IELs by hierarchical
clustering indicated that these cells showed close similarities
with intestinal lamina propria NKp46+ NK cells and NKp46+
ILC1s but differed from ILC2 and ILC3 subsets. Detailed cytokine
and effector molecule gene expression analysis confirmed a
group 1 ILC profile for CD8aaLy49E+ IELs, with the presence
of large numbers of transcripts for Ccl3, Ccl5, Ifng, Tnf, Gzma,
and Gzmb. We also demonstrated that CD8aaLy49E+ IELs
were IL-15 dependent. As NK cells as well as lamina propria
ILC1s, but not intraepithelial ILC1 cells, are dependent on IL-15
signaling (Fuchs et al., 2013; Klose et al., 2014; Van Kaer et al.,
2014), these data further support the group 1 ILC-like nature of
CD8aaLy49E+ IELs. However, intestinal CD8aaLy49E+ IELs
are not NK cells. Comparing our data with the recently described
NKcell-distinct core signature, i.e., a set of transcripts common to
ILC1 fromall tissues that aremorehighly expressed than inNKcell
subsets and that also showhigh expression in ILC2 and ILC3sub-
sets (Robinette et al., 2015), CD8aaLy49E+ IELs showed strong
expression of the NK cell-distinct ILC core signature genes,
whereas CD8aaLy49E+ IELs displayed low expression of NK
cell-specific signature genes. Other arguments are that, contrary
to NK cells, CD8aaLy49E+ IELs have an NKp46 NK1.1/low
phenotype and express CD49a, a marker present on tissue-resi-
dent ILC1s and absent on NK cells (Klose et al., 2014; Robinette
et al., 2015). In addition, these cells do not express the typical
NK receptor NKG2D, and, most importantly, CD8aaLy49E+
IELs develop independently of Eomes and are dependent on
T-bet. Finally, although CD8aaLy49E+ IELs contain cytoplasmic
granules and expressperforin, granzymeA, andgranzymeB, they
do not kill the NK-sensitive YAC-1 cells.
There are also important differences between the intestinal
CD8aaLy49E+ IELs described in the present paper and the pre-
viously described intestinal intraepithelial and lamina propria
ILC1s. In contrast to CD8aaLy49E+ IELs, murine intestinal intra-
epithelial ILC1s have an NKp46+NK1.1+ phenotype and are
negative for CD103. In addition, intraepithelial ILC1s are largely
independent of IL-15Ra (Fuchs et al., 2013), which is opposite
to what we observed for CD8aaLy49E+ IELs. Alongside and
unlike CD8aaLy49E+ IELs, lamina propria ILC1s have an
NKp46+NK1.1+ phenotype and express CD127, CD90, and
CD117 (Klose et al., 2014). Thus, although CD8aaLy49E+ IELs
have group 1 ILC characteristics, including their overall tran-
scriptional profile, these cells have several crucial differences
when compared to NK cells and previously described intestinal
ILC1s.
CD8aaLy49E+ IELs, in contrast to CD8aa+Ly49E+ IELs,
showed increased transcript levels of the transcription factors
RORgt, RORa, and Eomes. As these three transcription factors
are associated with the ILC3, ILC2, and NK cell lineages, respec-
tively, this could indicate that CD8aaLy49E+ IELs represent
a developmental intermediate and/or an activation-induced
fraction of some larger, previously described population. There-
fore, we tested the in vivo stability of this population upon trans-
fer to immunodeficient recipients. The results show that CD8aa
Ly49E+ IELs represent a stable population, with 80%–97%
retention of Ly49E expression.1440 Cell Reports 19, 1431–1443, May 16, 2017A role for both intraepithelial and lamina propria ILC1s in medi-
ating Th1-type immune response has been demonstrated (Fuchs
et al., 2013; Klose et al., 2014). Intestinal NKp46-negative
CD8aaLy49E+ IELs expressed Il12r, Il2rb, and, in comparison
to NKp46-expressing NK cells and NKp46+ ILC1s, expressed
even higher Il18r1 levels, which may reflect their ability to be
readily stimulated by IL-18 in conjunction with IL-12 and/or IL-
15 to express IFN-g. We evaluated IFN-g production by these
cells following incubation in the presence of IL-12 alone, IL-
12 + IL-15, or IL-12 + IL-15 + IL-18. Whereas IL-12 alone induced
IFN-g, there was a progressive increase when IL-15 and IL-15 +
IL-18were added. Aswehavepreviously shown that uPA triggers
the Ly49E receptor (Van Den Broeck et al., 2008), we also stimu-
lated the Ly49E+ IELswith IL-12 + IL-15 + IL-18 in the presence of
uPA or BSA as a negative control. The presence of uPA did not
alter IFN-g production of cytokine-stimulated CD8aaLy49E+
or CD8aa+Ly49E+ IELs. Therefore, at present, we do not have
evidence for a functional role of the Ly49E receptor on
CD8aaLy49E+ IELs. However, this does not preclude a function
for Ly49E. We have shown before that Ly49E expression on NK
cells restrains IFN-g production and CD107 expression in an
Ly49E-dependent manner (Van Den Broeck et al., 2008). IFN-g
induction in these experiments required stimulation of cells
through an activating NK receptor. This can be generalized to
the functionof theother inhibitoryNK receptors, as their inhibitory
function has always been demonstrated in combination with trig-
gering of an activatingNK receptor. To thebest of our knowledge,
there have been no reports of inhibitory NK receptor function
in cytokine-mediated activation. Moreover, it has been shown
by others that IL-12 as well as IL-18 override the inhibitory
Ly49G2 receptor blockade for IFN-g production in Ly49D-trig-
gered or tumor cell-triggered NK cells, both in vitro and in vivo
(Ortaldo and Young, 2003). Therefore, a possible Ly49E function
on CD8aaLy49E+ IELs should not be discounted at this stage,
but additional work is needed in this context.
To discern whether CD8aaLy49E+ IELs contribute to Th1-
mediated immunity in vivo, we evaluated IFN-g production by
these cells 4 days following infection of NOD-SCID mice with
the parasite T. gondii. We show that CD8aaLy49E+ IELs ex-
press IFN-g in this model, more so than CD8aa+Ly49E+ IELs,
corroborating our in vitro data.
In parallel, we showed that intestinal CD8aa+Ly49E+ IELs
had several characteristics in common with iCD8a cells. CD8aa+
Ly49E+ cells had a CD45+CD11bintCD11cintCD103+c-kit
NKp46NK1.1 phenotype, as also described for iCD8a cells
(Van Kaer et al., 2014). Furthermore, we showed that these cells
expressCD49a, suggestinga tissue-resident ILC1-likephenotype
(Fuchs et al., 2013; Klose et al., 2014; Robinette et al., 2015).
CD8aa+Ly49E+ IELs had a lymphoid morphology and were gran-
ular, in accordance with high expression of Grzma and Grzmb of
iCD8a cells (Van Kaer et al., 2014). As well as this, CD8aa+
Ly49E+ IELs were dependent on IL-15-mediated signaling, and
total numbers were strongly reduced in gc/ mice. CD8aa+
Ly49E+ IELs expressed Id2, as do iCD8a cells. However, our mi-
croarray data indicated lower T-bet expression levels for CD8aa+
Ly49E+ as compared to CD8aaLy49E+ IELs, lamina propria NK
cells, and ILC1s, andCD8aa+Ly49E+ cellswere T-bet dependent,
whereas iCD8a are reportedly T-bet independent (Van Kaer et al.,
2014). In comparison with CD8aa+Ly49E+ IELs, CD8aaLy49E
IELs also had higher gene expression of Ccr9, Ifng, Tnf, Il2ra,
Il7r, Il18r, Il1r1, Podnl1, Tmem176a, and Tmem176b.
Conclusively, we have defined an intestinal intraepithelial
ILC1-like population that is distinct from the previously
described NKp46+NK1.1+CD160+ intraepithelial ILC1 population
(Fuchs et al., 2013), the NKp46+NK1.1+CD127+ lamina propria
ILC1 population (Klose et al., 2014), and also distinct from NK
cells. Of note, a recent paper also describes the existence of a
population of salivary gland group 1 ILCs distinct from both NK
and ILC1s, thus highlighting the heterogeneity of group 1 ILCs
at multiple mucosal sites (Cortez et al., 2016). Moreover, a
contemporary paper describes the presence of non-circulating
innate-like T cell receptor ab and gd lymphocytes, in addition
to ILC1-like cells, in mammary tissue (Dadi et al., 2016). Both
mammary innate-like T cells and ILC1-like cells express NK1.1,
CD103, and CD49a; express high T-bet levels; are negative
for CD127; and are IL-15 dependent. Thus, these cells show
many similarities to the intestinal NKp46CD8aaLy49E+ IELs
described in this paper. Most intriguingly, mammary-resident
innate-like T cells and ILC1-like cells express Ly49E (Dadi
et al., 2016). We can therefore conclude that Ly49E receptor
expression is characteristic for and restricted to specific tis-
sue-resident innate(-like) lymphocyte populations, including in-
testinal iCD8a cells (Van Kaer et al., 2014), intestinal innate-like
CD8aa+ T lymphocytes (Shires et al., 2001; Taveirne et al.,
2011; Van Acker et al., 2014), liver CD49a+ NK cells (Filtjens
et al., 2013), skin epidermal Vg3 T lymphocytes (Van Beneden
et al., 2002), mammary gland innate-like T and ILC1-like cells
(Dadi et al., 2016), and intestinal NKp46CD8aaLy49E+ IELs
(this paper).
EXPERIMENTAL PROCEDURES
Mice
C57BL/6WT,BALB/cNOD-SCID, andC57BL/6Rag/ andRag/gc/mice
were purchased from Charles River Laboratories. Eomes/ (Eomesfl/fl 3
T-Cre) (Arnold et al., 2008; Perantoni et al., 2005), Tbx21/ (Szabo et al.,
2002), Rorc(gt)Gfp/Gfp (Eberl et al., 2004), Il7ra/ (Peschon et al.,
1994), Il15ra/ (Kennedy et al., 2000), and RORgt-fm (Rorc(gt)-CreTg 3
Rosa26RYfp/+) mice (Eberl and Littman, 2004) were on a C57BL/6 background.
Both females and males were used at the age of 2–6 months. All animal
experimentation was performed after approval and according to the guidelines
of the Ethical Committee for Experimental Animals at the Faculty of Medicine
and Health Sciences of Ghent University, the Landesuntersuchungsamt
Koblenz, and the Landesverwaltungsamt Sachsen-Anhalt.
Intestinal IEL and Lamina Propria Lymphocyte Isolation
IELs were isolated from the small intestine as described previously (Van Acker
et al., 2014) (see the Supplemental Experimental Procedures). Briefly, small
intestinal fragments were mechanically digested in a Ca/Mg-free buffer, and
IELs were enriched by density gradient centrifugation. Thereafter, the small
intestinal fragments were dispase/collagenase treated, and lamina propria
lymphocytes (LPLs) were isolated by density gradient centrifugation (see the
Supplemental Experimental Procedures).
Immunofluorescence Staining and Antibodies
Following isolation, cells were labeled with antibodies for flow cytometric
analysis (see the Supplemental Experimental Procedures). Flow cytometry
was performed using a BD LSRII flow cytometer, and samples were
analyzed with FACSDiva Version 6.1.2 software (BD Biosciences) or FlowJo
8.7.1.Cell Sorting and Cytospin
CD3CD45+NKp46CD8aaLy49E+ and CD3CD45+NKp46CD8aa+Ly49E+
IELs were sorted to high purity (>98%) from the small intestine of NOD-SCID
mice using a BD FACSAria III cell sorter (BD Biosciences). For cytospins, cells
were spun onto a glass slide, fixed, and stained with Giemsa.
Microarray
Small intestinal CD3CD45+CD8aaLy49E+, CD3CD45+CD8aa+Ly49E+, and
CD3CD45+CD8aa+Ly49E IELs of NOD-SCID mice were sorted to high
purity (>98%) in three independent experiments using a BD FACSAria III cell
sorter (BD Biosciences). Transcriptome analysis was performed using the
Affymetrix Mouse Gene 1.0ST Array (Affymetrix) (see the Supplemental Exper-
imental Procedures).
In Vitro Cell Stimulation
Intestinal IELs were isolated from NOD-SCID mice and cultured in complete
RPMI medium in the presence of IL-12 (20 ng/mL; R&D Systems), and/or IL-
15 (10 ng/mL; R&D Systems), and/or IL-18 (2.5 ng/mL; Medical and Biological
Laboratories) for 15 hr. Alternatively, wells were precoatedwith uPA (Molecular
Innovations) or BSA at 200 ng/mL for 6 hr, before the different cell populations
were cultured in the presence of different cytokine combinations for an
additional 15 hr. In both experimental conditions, Brefeldin A (Golgistop, BD
Biosciences) (1 mg/mL) was added during the last 12 hr. Cells were harvested
and stained as described.
Cytotoxicity Assay
Freshly isolated NOD-SCID intestinal intraepithelial NK (CD3CD45+NKp46+),
CD3CD45+NKp46CD8aaLy49E+, and CD3CD45+NKp46CD8aa+Ly49E+
cell populations and spleen NK cells were sorted to high purity (>98%) and
used as effectors. Killing of the NK-sensitive YAC-1 (European Collection of
Cell Cultures) target cells was assessed in a standard 51Cr-release assay, as
previously described (Filtjens et al., 2013). Percentage specific lysis was calcu-
lated as 100 3 ([experimental release  spontaneous release]/[total release 
spontaneous release]).
T. gondii Infection
T. gondii cysts of type II strain ME 49 were harvested from the brains
of female NMRI mice infected intraperitoneally with T. gondii cysts
8–10 months earlier. Brains obtained from infected mice were mechanically
homogenized in 1 mL sterile PBS, and the cysts were counted using a
light microscope. NOD-SCID mice were infected by oral gavage with ten
T. gondii cysts.
Statistical Analysis
Statistical analysis was carried out using PASW Statistics 22 Software (SPSS)
or GraphPad Prism5 Software. Data were analyzed using the non-parametric
two-tailed Mann-Whitney U test. A p value% 0.05 was considered statistically
significant.
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